GSK
GSK
847 hedge funds and large institutions have $10.4B invested in GSK in 2023 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 304 increasing their positions, 269 reducing their positions, and 69 closing their positions.
226% more call options, than puts
Call options by funds: $414M | Put options by funds: $127M
46% more capital inflows, than outflows
Capital inflows: $896M | Capital outflows: $614M
43% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 69
13% more repeat investments, than reductions
Existing positions increased: 304 | Existing positions reduced: 269
9% more funds holding in top 10
Funds holding in top 10: 11 → 12 (+1)
2% more funds holding
Funds holding: 828 → 847 (+19)
0.38% more ownership
Funds ownership: 13.58% → 13.96% (+0.38%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$157M |
| 2 |
Holocene Advisors
New York
|
+$74.4M |
| 3 |
Millennium Management
New York
|
+$53.6M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$45.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$44.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$127M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$102M |
| 3 |
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$45.7M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$45.4M |
| 5 |
Camber Capital Management
Boston,
Massachusetts
|
-$44.4M |
GSK Hedge Fund Activity: Q3 2023 in Review
847 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q3 2023, worth a combined $10.4B — up 4.6% from $9.9B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new GSK positions and 69 closed out — a net gain of 30 holders — while 304 added to existing stakes and 269 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $157M. The largest seller was Goldman Sachs, cutting an estimated $127M.
- 847 institutional investors held GSK (GSK) as of Q3 2023, up from 828 in Q2 2023.
- Funds reported $10.4B of GSK stock for Q3 2023, up 4.6% quarter-over-quarter.
- 99 funds opened new GSK positions in Q3 2023 and 69 closed out, a net change of +30 holders.
- The largest GSK buyer in Q3 2023 was Deutsche Bank, an estimated $157M added.
- The largest GSK seller in Q3 2023 was Goldman Sachs, an estimated $127M sold.
Based on aggregated 13F filings for Q3 2023.